Research peptide blend · Fact sheet
Semax + Selank
Also known as Semax/Selank blend
Semax + Selank combines Semax and Selank. Human evidence for the exact blend is not established; studies of individual ingredients do not validate the mixture.
What is Semax + Selank?
Semax and Selank are discussed together under this name. Ratios, salts and formulations can differ between products.
A Semax/Selank mixture is not equivalent to either original medicine, and acetylated or amidated variants introduce further differences.
Benefits & claims
Interest centers on attention, anxiety and stress-related symptoms.
What the evidence supports
- A Semax stroke study and a Selank anxiety study concern different populations and single-agent or adjunct contexts.
- No combined-product efficacy result follows from those studies.
- Claims of simultaneous stimulation and calming require direct testing of the mixture.
Research areas
- Interest centers on attention, anxiety and stress-related symptoms.
Dosage & frequency
No established human regimenThe reviewed sources do not establish a human treatment amount or frequency for Semax + Selank. Animal and laboratory exposures are not human regimens.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
Formulation differences
- A Semax/Selank mixture is not equivalent to either original medicine, and acetylated or amidated variants introduce further differences.
- No published ingredient regimen can be assembled into a supported regimen for this combination.
Interactions & precautions
- The reviewed sources do not establish a comprehensive human interaction profile for this exact substance or combination.
What is still unresolved
- Human efficacy and adverse-event rates for the exact formulation
- Chemical compatibility, stability and ingredient identity
- Whether combined effects differ from the ingredients alone
Side effects & risks
- FDA identifies inadequate safety information and potential peptide-related impurity or immune-reaction concerns for these ingredients.
- Interaction with psychiatric medicines and repeated intranasal or systemic exposure to the blend remain insufficiently characterized.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Limited or unclear evidenceThe reviewed sources do not establish efficacy or a human regimen for this exact combination. Ingredient-only experiments cannot show that the mixture is effective, synergistic or safer.
Studies
Small older human study with important design, reporting, and generalizability limits.
Small Russian-language randomized trial with limited accessible reporting and generalizability.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
No attributable personal accounts were found in the sources reviewed.
Approval status
There is no FDA-approved Semax + Selank product or established approved use for this combination. Ingredient approvals, where present, do not transfer to the blend.
No FDA-approved product for this entry
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Human efficacy and adverse-event rates for the exact formulation
- Chemical compatibility, stability and ingredient identity
- Whether combined effects differ from the ingredients alone
Summary
Claims of simultaneous stimulation and calming require direct testing of the mixture.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- pubmedControlled clinical study of Semax in ischemic stroke
Small older human study with important design, reporting, and generalizability limits.
- pubmedRandomized study of Selank in anxiety disorders
Small Russian-language randomized trial with limited accessible reporting and generalizability.
- fdaFDA: safety concerns for nominated bulk substances
Ingredient-specific uncertainties; compounding consideration is separate from FDA drug approval.